WACKER Eddyville Plant Celebrates 25 Years

Author

Slice of Manufacturing Team
June 18, 2024

Key Highlights:

  • Celebrating 25 years of cyclodextrin production at WACKER's Eddyville plant.

  • World's sole commercial-scale manufacturer of Alpha and Gamma cyclodextrins.

  • ISO 9001, ISO 14001, FSSC 22000, and EXCiPACT GMP certified facility.

  • Central to WACKER's global Biotech and Biopharma network, supplying global customers.

Source (PR Newswire)

Notable Quotes:

❝

"Eddyville plays a central role within our global network of Biotech and Biopharma sites. From Iowa we supply all our global cyclodextrin customers. It is an important pillar of the BIOSOLUTIONS portfolio and our growth strategy. Our goal is to reach one billion Euros in sales by the year 2030. This site is essential to help us accomplish this ambition."

Susanne Leonhartsberger, President at WACKER BIOSOLUTIONS
❝

"We congratulate WACKER on 25 years of business in Iowa. We thank the corporation for their dedication in manufacturing cyclodextrin for Iowans and those across the global market. We honor this business and its contribution to the community."

Kim Reynolds, Governor at Iowa and Adam Gregg, Lt. Governor at Iowa
❝

"WACKER is a valuable member of our innovative industry and the local communities in which it operates. This milestone is also a celebration of our industry's signature performance initiative under Responsible Care, demonstrating WACKER's commitment to safeguarding human and environmental health as it develops solutions to improve quality of life around the globe."

Chris Jahn, President & CEO at American Chemistry Council

Our Take:

WACKER Chemical Corporation's 25th anniversary of its Eddyville bioprocessing plant underscores its pivotal role in the production of high-quality cyclodextrins, essential for the food and pharmaceutical industries. The plant's strategic location in Iowa's corn belt and its state-of-the-art certifications highlight its commitment to excellence and sustainability. As WACKER aims for significant growth by 2030, the Eddyville site remains a cornerstone of its global operations, exemplifying innovation and dedication to quality. This milestone not only celebrates past achievements but also sets the stage for future advancements in bioprocessing and biotechnology.